Model DetailsMesodermal cell/mesoblast sarcoma
Model Name |
Mesodermal cell/mesoblast sarcoma | Strain |
C3HeB/De |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonym |
subcutaneous sarcoma (sarcoma-subcutaneous) |
Strain Synonyms |
C3He • C3HeB Deringer • C3HeB/Deringer • C3H • C3HeB • C3HeB/De • C3He/De |
Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
---|---|---|---|---|---|
Mesodermal cell/mesoblast | Female |
7.1% (7 of 99 mice) |
~22 months |
|
Deringer MK, J Natl Cancer Inst 1959;22():995-1002 |
Mesodermal cell/mesoblast | Female |
1.9% (3 of 155 mice) |
~26 months |
|
Deringer MK, J Natl Cancer Inst 1959;22():995-1002 |
Mesodermal cell/mesoblast | Female |
1.2% (1 of 82 mice) |
24 months |
|
Deringer MK, J Natl Cancer Inst 1959;22():995-1002 |
Mesodermal cell/mesoblast | Female |
7.1% (7 of 99 mice) |
|
Murphy ED, 1966;():521-62 | |
Mesodermal cell/mesoblast | Female |
1.9% (3 of 155 mice) |
|
Murphy ED, 1966;():521-62 | |
Mesodermal cell/mesoblast | Female |
1.2% (1 of 82 mice) |
|
Murphy ED, 1966;():521-62 |